
- Professional Content
- Finance
Samsung Biologics vs. Lonza: Challenging the Global CDMO Leader in 2024
2024.09.22 Caution
- -
The information contained in this document has been obtained from reliable sources and data by our satellite utilization division; however, accuracy and completeness cannot be guaranteed. Therefore, we recommend using this information as reference material and making decisions under your own judgment and responsibility when utilizing it.
- -
Our company does not assume legal responsibility for the outcomes arising from the utilization of this information.
- -
The intellectual property rights of this document belong to our company, and unauthorized reproduction, copying, or distribution is prohibited according to copyright law.